HomeAI · summaries
Storia in 4 fonti
Wall Street May Be Mispricing Medtronic, Analyst Says - Medtronic (NYSE:MDT)
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Medtronic to Report Fiscal Fourth Quarter Results; These Most Accurate Analysts Revise Forecasts Ahead Of
Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst…
- ·
How To Earn $500 A Month From Medtronic Stock After Q4 Earnings - Medtronic (NYSE:MDT)
Medtronic to report Q4 2026 results with expected revenue of $9.61B and EPS of $1.55. Dividend yield is 3.83%.
